Texas Rangers pitcher Jacob deGrom successfully underwent reconstructive elbow surgery on Monday to address a torn ulnar collateral ligament (UCL), according to manager Bruce Bochy. The procedure, often referred to as Tommy John surgery, was performed by Rangers team physician Dr. Keith Meister. A typical recovery timeline for this type of surgery is estimated to be 12-14 months.

DeGrom, who turned 35 shortly after the surgery, signed a lucrative five-year, $185 million contract with the Rangers this past offseason after spending his previous nine seasons with the New York Mets. His tenure with the Mets was marked by periods of injury, including missing significant time in both 2021 and 2022 due to forearm and elbow issues, as well as a stress reaction in his scapula.

Despite his injury history, deGrom started the 2023 season strong, leading the Rangers to victory in each of his six starts. He boasted an impressive 2-0 record with a 2.67 ERA, striking out 45 batters while allowing only four walks in 30 1/3 innings pitched. His last outing was on April 28th against the New York Yankees, which he exited early due to renewed injury concerns.

An initial MRI following the Yankees game revealed inflammation, but subsequent bullpen sessions led to further examination. A follow-up scan revealed more extensive structural damage to the UCL, prompting the decision for season-ending surgery. This marks deGrom's second Tommy John surgery, having previously undergone the procedure in the minor leagues after being drafted by the Mets in 2010. He missed the entire 2011 season due to the initial surgery.

The surgery will activate a conditional option in deGrom's contract, extending his deal with the Rangers through 2028. The value of this sixth-year option, which can range from $20 million to $37 million, is contingent on his performance and health following the 2027 season.